NO971381D0 - Kombinasjon av prostacyklin med et östrogen eller progestin for forhindring og behandling av atherosklerotisk vaskulær sykdom, innbefattende preeklampsi, og for behandling av hypertensjon, og for hormonerstatningsterapi - Google Patents
Kombinasjon av prostacyklin med et östrogen eller progestin for forhindring og behandling av atherosklerotisk vaskulær sykdom, innbefattende preeklampsi, og for behandling av hypertensjon, og for hormonerstatningsterapiInfo
- Publication number
- NO971381D0 NO971381D0 NO971381A NO971381A NO971381D0 NO 971381 D0 NO971381 D0 NO 971381D0 NO 971381 A NO971381 A NO 971381A NO 971381 A NO971381 A NO 971381A NO 971381 D0 NO971381 D0 NO 971381D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- progestin
- prostacyclin
- estrogen
- hypertension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/310,950 US6613757B1 (en) | 1994-09-22 | 1994-09-22 | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
PCT/US1995/012336 WO1996009826A2 (en) | 1994-09-22 | 1995-09-22 | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971381D0 true NO971381D0 (no) | 1997-03-24 |
NO971381L NO971381L (no) | 1997-05-22 |
Family
ID=23204746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971381A NO971381L (no) | 1994-09-22 | 1997-03-24 | Kombinasjon av prostacyklin med et östrogen eller progestin for å hindre og behandle atherosklerotiske karsykdommer inkludert preeklampsi og for behandling av höyt blodtrykk, og for hormonerstatningsterapi |
Country Status (16)
Country | Link |
---|---|
US (1) | US6613757B1 (no) |
EP (1) | EP0790827A2 (no) |
JP (1) | JPH10506899A (no) |
AU (1) | AU699699B2 (no) |
BG (1) | BG101349A (no) |
BR (1) | BR9509030A (no) |
CA (1) | CA2200858A1 (no) |
CZ (1) | CZ88997A3 (no) |
HU (1) | HUT76959A (no) |
IL (1) | IL115399A0 (no) |
IS (1) | IS4450A (no) |
NO (1) | NO971381L (no) |
PL (1) | PL319295A1 (no) |
SK (1) | SK38697A3 (no) |
WO (1) | WO1996009826A2 (no) |
ZA (1) | ZA958047B (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
US6056972A (en) | 1997-02-26 | 2000-05-02 | Dimera, Llc | Method for reducing coronary artery reactivity |
US6602487B1 (en) | 1997-02-26 | 2003-08-05 | Dimera Incorporated | Methods and tests for producing and for inhibiting coronary artery vasospasms |
US20040167111A1 (en) * | 1998-04-15 | 2004-08-26 | Michael Oettel | Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy |
US6844333B1 (en) * | 1999-03-26 | 2005-01-18 | The Trustees Of The University Of Pennsylvania | Method of treating atherosclerosis |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
US7056906B2 (en) * | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US7335362B2 (en) * | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
US7572780B2 (en) | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
SI1624878T1 (sl) * | 2003-05-22 | 2007-02-28 | Pantarhei Bioscience Bv | Uporaba sestavkov, ki obsegajo estrogensko komponento, za zdravljenje in preprecevanje muskuloskeletne bolecine |
WO2005110462A2 (en) | 2004-05-04 | 2005-11-24 | Children's Medical Center Corporation | Methods and compositions for treatment of preeclampsia |
EP1761231A1 (en) * | 2004-06-07 | 2007-03-14 | Duramed Pharmaceuticals, Inc. | Dispenser for progestin used for acute and maintenance treatment of dub |
MX2007003522A (es) | 2004-09-24 | 2007-06-11 | Beth Israel Hospital | Complicaciones del embarazo. |
US20090286271A1 (en) * | 2006-05-31 | 2009-11-19 | Karumanchi Ananth S | Methods of Diagnosing and Treating Complications of Pregnancy |
UY33103A (es) * | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP3174542A4 (en) | 2014-07-29 | 2018-01-03 | TherapeuticsMD, Inc. | Transdermal cream |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4189795A (en) * | 1978-09-20 | 1980-02-26 | Conti Angelo J | Toilet flush valve |
US4879285A (en) * | 1986-08-22 | 1989-11-07 | Royal North Shore Hospital And Area Health Service | Fertility control |
US5895783A (en) * | 1993-07-16 | 1999-04-20 | Schering Aktiengesellschaft | Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
-
1994
- 1994-09-22 US US08/310,950 patent/US6613757B1/en not_active Expired - Fee Related
-
1995
- 1995-09-22 JP JP8511990A patent/JPH10506899A/ja not_active Withdrawn
- 1995-09-22 WO PCT/US1995/012336 patent/WO1996009826A2/en not_active Application Discontinuation
- 1995-09-22 BR BR9509030A patent/BR9509030A/pt not_active Application Discontinuation
- 1995-09-22 PL PL95319295A patent/PL319295A1/xx unknown
- 1995-09-22 CA CA002200858A patent/CA2200858A1/en not_active Abandoned
- 1995-09-22 AU AU37275/95A patent/AU699699B2/en not_active Ceased
- 1995-09-22 SK SK386-97A patent/SK38697A3/sk unknown
- 1995-09-22 IL IL11539995A patent/IL115399A0/xx unknown
- 1995-09-22 ZA ZA958047A patent/ZA958047B/xx unknown
- 1995-09-22 HU HU9701502A patent/HUT76959A/hu unknown
- 1995-09-22 CZ CZ97889A patent/CZ88997A3/cs unknown
- 1995-09-22 EP EP95935145A patent/EP0790827A2/en not_active Withdrawn
-
1997
- 1997-03-21 BG BG101349A patent/BG101349A/xx unknown
- 1997-03-21 IS IS4450A patent/IS4450A/is unknown
- 1997-03-24 NO NO971381A patent/NO971381L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IS4450A (is) | 1997-03-21 |
WO1996009826A3 (en) | 1996-05-23 |
SK38697A3 (en) | 1998-05-06 |
WO1996009826A2 (en) | 1996-04-04 |
CA2200858A1 (en) | 1996-04-04 |
NO971381L (no) | 1997-05-22 |
MX9702207A (es) | 1998-05-31 |
AU3727595A (en) | 1996-04-19 |
ZA958047B (en) | 1996-12-20 |
JPH10506899A (ja) | 1998-07-07 |
HUT76959A (hu) | 1998-01-28 |
PL319295A1 (en) | 1997-08-04 |
CZ88997A3 (cs) | 1998-02-18 |
EP0790827A2 (en) | 1997-08-27 |
BG101349A (en) | 1998-03-31 |
BR9509030A (pt) | 1997-11-25 |
US6613757B1 (en) | 2003-09-02 |
IL115399A0 (en) | 1995-12-31 |
AU699699B2 (en) | 1998-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971381D0 (no) | Kombinasjon av prostacyklin med et östrogen eller progestin for forhindring og behandling av atherosklerotisk vaskulær sykdom, innbefattende preeklampsi, og for behandling av hypertensjon, og for hormonerstatningsterapi | |
FI971969A0 (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
HK1042475A1 (zh) | 用於治療炎癥的取代噻唑 | |
NO992140L (no) | Progesteron for behandling eller redusering av ischemi | |
AU3497295A (en) | Compositions and methods for the treatment of body weight disorders, including obesity | |
AU3218197A (en) | Natural progesterone for the treatment of side effects of progestins and progesterone analogues | |
HK1000697A1 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
AU3548795A (en) | Benzopyranopyrazolyl derivatives for the treatment of inflammation | |
AU6392496A (en) | The combination of topical nasal antihistamines and topical nasal steroids | |
CA2069483A1 (en) | Steroid sulphatase inhibitors | |
ZA965938B (en) | Use of MP52 of MP121 for the treatment and prevention of diseases of the nervous system. | |
NO20014674D0 (no) | Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser | |
World Health Organization | Guidelines for the primary prevention of mental, neurological and psychosocial disorders. 5. Staff burnout | |
IL120558A0 (en) | New hormonal medicaments and their use for the correction of oestrogenic deficiencies | |
EP1039883A4 (en) | METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES | |
AU1104392A (en) | Method for the treatment of hepatic failure and disease | |
AU7484596A (en) | Combination therapy for the treatment of diabetes and obesity | |
IL129622A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
EP0689839A3 (en) | Use of adenosine triphosphatase inhibitors for the manufacture of a medicament for the treatment of beta-amyloid peptide-associated disorders | |
EP0981357A4 (en) | METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | |
IL129624A0 (en) | Novel (+)-enantiomers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
IL129623A0 (en) | Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
AU5558498A (en) | Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis | |
IL129618A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |